| Date | Form | Description | Docs | XBRL | Pages |
| 07/17/14 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/17/14 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/17/14 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/17/14 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 07/15/14 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
43 | |
| 07/15/14 | 8-K | Current report filing |
|
54 | |
| 07/14/14 | 8-K | Current report filing |
|
5 | |
| 06/26/14 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
3 | |
| 06/26/14 | DEF 14A | Definitive proxy statements |
|
59 | |
| 06/17/14 | UPLOAD | SEC-generated letter |
|
1 |
Latest News & Events
Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization
Read More...Anixa Biosciences Receives Notice of Allowance from Mexican Institute of Industrial Property (IMPI) for Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic
Read More...